US2011263962A1PendingUtilityA1
Brain function decoding process and system
Individually held — no corporate assignee on recordPriority: Oct 20, 2004Filed: Apr 8, 2011Published: Oct 27, 2011
Est. expiryOct 20, 2024(expired)· nominal 20-yr term from priority
Inventors:Donald H. Marks
A61B 5/16A61B 5/055
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of interpreting cognitive response to a stimulus is disclosed. The method includes collecting baseline neural activity data from a subject absent a stimulus. Neural activity data is collected while the subject is being stimulated through exposure to a stimulus. A unique three-dimensional cognitive engram is then plotted representative of cerebral regions of stimulated neural activity caused by the stimulus. A novel graphical representation is plotted in three dimensions to indicate the brain region response unique to that stimulus.
Claims
exact text as granted — not AI-modified1 . A method of interpreting cognitive response comprising:
collecting baseline neural activity data that maps a neural activation absent a stimulus onto neuronal structure of a subject brain; exposing said subject to said stimulus; collecting stimulated neural activity data from said subject while said subject is exposed to said stimulus; and plotting a unique three-dimensional cognitive engram representative of the stimulated neural activity caused by said stimulus.
2 . The method of claim 1 further comprising: compiling said cognitive engram in a database containing a plurality of engrams.
3 . The method of claim 2 wherein said plurality of engrams is derived from a plurality of stimuli that is different than said stimulus.
4 . The method of claim 1 wherein said stimulus is sensory.
5 . The method of claim 1 wherein said stimulus is viewing an image.
6 . The method of claim 1 wherein said stimulus is a verbal question of recall.
7 . The method of claim 1 wherein said stimulus is chemical.
8 . The method of claim 7 further comprising correlating said cognitive engram with a regimen of administration of said chemical.
9 . The method of claim 1 wherein said subject is a human.
10 . The method of claim 1 wherein said baseline data and said stimulated data are collected as a plurality of tomographic scans compiled as two-dimensional slices.
11 . The method of claim 1 further comprising performing an operation on said stimulated data prior to plotting said cognitive engram, said operation selected from the group consisting of: correcting for subject movement artifact, reprocessing sequential images, blood oxygen level dependency consideration and statistical deformation modeling.
12 . The method of claim 1 further comprising harvesting subject movement artifact overlap data to increase the quantity of said stimulated data prior to plotting said cognitive engram.
13 . The method of claim 1 wherein said baseline data and said stimulated data are derived from arterial spin labeling and dynamic susceptibility weighted contrast enhanced magnetic resonance imaging.
14 . The method of claim 1 wherein said baseline and said stimulated data are derived from magnetization transfer and diffusion-tensor magnetic resonance imaging with whole brain tissue histogram analysis.
15 . A graphical representation of cognitive activity comprising a three-dimensional plot matching of brain imaging scan data with a stimulus, said plot prepared absent input of stimulus encoding rules within a subject brain.
16 . The graphical representation of claim 15 wherein said plot is unique to said stimulus and reproducible upon reintroducing said stimulus.
17 . A method of questioning a subject comprising:
generating a graphical representation according to claim 15 for a known truth and a second graphical representation according to claim 15 for a known falsehood; and generating a graphical representation according to claim 15 in response to a stimulus intended to elicit a true or false cognitive response in said subject.
18 . A method of objectively measuring subject status comprising:
generating a graphical representation according to claim 15 from said subject and comparing said graphical representation to a control.
19 . The method of claim 18 wherein a subject's state is selected from the group consisting of: physiology, psychological disease state, response to a chemical stimulus, and a level of pain.
20 . The method of claim 19 wherein the subject's state is response to a chemical stimulus, wherein said chemical stimulus is induced by administration of a drug selected from the group consisting of: interferon, quinolones, neuroleptics, serotonin-active drugs, and alcohol.Join the waitlist — get patent alerts
Track US2011263962A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.